Clinical Trials Directory

Trials / Conditions / Recurrent Hairy Cell Leukemia

Recurrent Hairy Cell Leukemia

7 registered clinical trials studyying Recurrent Hairy Cell Leukemia — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia
NCT06965114
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingVenetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
NCT06311227
National Cancer Institute (NCI)Phase 2
CompletedFlotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
NCT04681105
City of Hope Medical CenterPhase 1
CompletedCC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymph
NCT04578600
Joseph TuscanoPhase 1
Active Not RecruitingCellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chron
NCT02153580
City of Hope Medical CenterPhase 1
Active Not RecruitingIbrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
NCT01841723
National Cancer Institute (NCI)Phase 2
RecruitingCladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
NCT00412594
M.D. Anderson Cancer CenterPhase 2